Zynerba Pharmaceuticals, Inc.

NASDAQ:ZYNE

1.3 (USD) • At close October 10, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2022202120202019201820172016201520142013
Assets:
Current Assets:
Cash & Cash Equivalents 50.64167.80859.15770.06359.76462.5130.96641.5139.3310.155
Short Term Investments 0000000000
Cash and Short Term Investments 50.64167.80859.15770.06359.76462.5130.96641.5139.3310.155
Net Receivables 1.2259.589.04314.6143.4453.9843.6140.35700.035
Inventory 00000001.49400
Other Current Assets 2.9092.8315.1662.3793.7471.7341.8310.0521.080
Total Current Assets 54.77580.2273.36687.05666.95568.22836.41143.41611.5950.689
Non-Current Assets:
Property, Plant & Equipment, Net 0.7460.9520.6910.7090.3720.1650.1430.2280.020.048
Goodwill 0000000000
Intangible Assets 0000000000
Goodwill and Intangible Assets 0000000000
Long Term Investments 0000000000
Tax Assets 0000000000
Other Non-Current Assets 000000.662000.0021.124
Total Non-Current Assets 0.7460.9520.6910.7090.3720.8270.1440.2280.0221.172
Total Assets 55.52181.17274.05787.76567.32769.05436.55443.64411.6171.861
Liabilities & Equity:
Current Liabilities:
Account Payables 1.9431.7992.5234.7414.4623.3551.8480.8230.3140.308
Short Term Debt 0.2150.2090.110.244000000.125
Tax Payables 0000000000
Deferred Revenue 000000.1720.8340.8411.121.041
Other Current Liabilities 7.0157.89711.2817.0745.2643.9154.2852.2731.7110.088
Total Current Liabilities 9.1739.90413.91312.0589.7267.4436.9673.9383.1461.562
Non-Current Liabilities:
Long Term Debt 0.120.35400.11000000.375
Deferred Revenue Non-Current 000000.6620001.12
Deferred Tax Liabilities Non-Current 0000000000
Other Non-Current Liabilities 0000000000
Total Non-Current Liabilities 0.120.35400.1100.6620016.5231.495
Total Liabilities 9.29210.25813.91312.1689.7268.1056.9673.93819.6683.058
Equity:
Preferred Stock 0000000003.162
Common Stock 0.0480.0410.030.0230.0180.0140.010.0090.0020
Retained Earnings -274.517-239.481-202.172-150.836-117.892-77.981-45.969-22.58-10.029-4.359
Accumulated Other Comprehensive Income/Loss 0000-0.26300000
Other Total Stockholders Equity 320.698310.354262.286226.409175.739138.91775.54662.2771.9750
Total Shareholders Equity 46.22970.91360.14475.59757.60260.9529.58739.706-8.052-1.197
Total Equity 46.22970.91360.14475.59757.60260.9529.58739.706-8.052-1.197
Total Liabilities & Shareholders Equity 55.52181.17274.05787.76567.32769.05436.55443.64411.6171.861